Pasar al contenido principal

POTENCIANDO LA RESPUESTA ANTIVIRAL EN PEZ: DESDE EL DISEÑO RACIONAL DE PROFILACTICOS A LA RESPUESTA IN VIVO

RTI2018-096957-B-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immunomodulatory lectin-like peptides for fish erythrocytes-targeting as potential antiviral drug delivery platforms

  • Salvador-Mira, Maria
  • Chico, Veronica|||0000-0001-6983-2786
  • Arostica, Mónica
  • Guzmán, Fanny|||0000-0002-7829-0568
  • Roher Armentia, Nerea|||0000-0002-6659-4038
  • Perez Garcia-Estañ, Luis|||0000-0003-4078-8763
  • Ortega-Villaizan, Maria del Mar|||0000-0003-2065-0601
One of the challenges of science in disease prevention is optimizing drug and vaccine delivery. Until now, many strategies have been employed in this sector, but most are quite complex and labile. To overcome these limitations, great efforts are directed to coupling drugs to carriers, either of natural or synthetic origin. Among the most studied cell carriers are antigen-presenting cells (APCs), however, red blood cells (RBCs) are positioned as attractive carriers in drug delivery due to their abundance and availability in the body. Furthermore, fish RBCs have a nucleus and have been shown to have a strong involvement in modulating the immune response. In this study, we evaluated the binding of three peptides to rainbow trout RBCs, two lectin-like peptides and another derived from Plasmodium falciparum membrane protein, in order to take advantage of this peptide-RBCs binding to generate tools to improve the specificity, efficacy, immunostimulatory ef-fect, and safety of the antiviral therapeutic or prophylactic administration systems currently used.